Background: Many acute stroke trials have given neutral results. Sub-optimal statistical analyses may be failing to detect efficacy. Methods which take account of the ordinal nature of functional outcome data are more efficient. We compare sample size calculations for dichotomous and ordinal outcomes for use in stroke trials. Methods Data from stroke trials studying the effects of interventions known to positively or negatively alter functional outcome – Rankin Scale and Barthel Index – were assessed. Sample size was calculated using comparisons of proportions, means, medians (according to Payne), and ordinal data (according to Whitehead). The sample sizes gained from each method were compared using Friedman 2 way ANOVA. Results Fifty...
Common outcome scales in acute stroke trials are ordered categorical or pseudocontinuous in structur...
Objective: To compare how 3 common representations (ordinal vs dichotomized as 0–1/2–6 or 0–2/3–6) o...
Background and Purpose— There is a lack of agreement regarding measuring the effects of stroke treat...
Background Many acute stroke trials have given neutral results. Sub-optimal statistical analyses ma...
Background Many acute stroke trials have given neutralresults. Sub-optimal statistical analyses may ...
Most large acute stroke trials have shown no treatment effect. Functional outcome is routinely used ...
Background and Purpose— Most large acute stroke trials have been neutral. Functional outcome is usua...
BACKGROUND AND PURPOSE: Vascular prevention trials mostly count "yes/no" (binary) outcome events, eg...
BACKGROUND AND PURPOSE: Most large acute stroke trials have been neutral. Functional outcome is usua...
ObjectivesUnderpowered trials risk inaccurate results. Recruitment to stroke rehabilitation randomis...
Background and Purpose—Only a few randomized controlled trials in acute stroke have shown a treatmen...
OBJECTIVES: Underpowered trials risk inaccurate results. Recruitment to stroke rehabilitation random...
Background and purpose: Arguments persist as to whether parametric or nonparametric methods should b...
Background and Purpose—Vascular prevention trials mostly count “yes/no” (binary) outcome events, eg,...
Common outcome scales in acute stroke trials are ordered categorical or pseudocontinuous in structur...
Common outcome scales in acute stroke trials are ordered categorical or pseudocontinuous in structur...
Objective: To compare how 3 common representations (ordinal vs dichotomized as 0–1/2–6 or 0–2/3–6) o...
Background and Purpose— There is a lack of agreement regarding measuring the effects of stroke treat...
Background Many acute stroke trials have given neutral results. Sub-optimal statistical analyses ma...
Background Many acute stroke trials have given neutralresults. Sub-optimal statistical analyses may ...
Most large acute stroke trials have shown no treatment effect. Functional outcome is routinely used ...
Background and Purpose— Most large acute stroke trials have been neutral. Functional outcome is usua...
BACKGROUND AND PURPOSE: Vascular prevention trials mostly count "yes/no" (binary) outcome events, eg...
BACKGROUND AND PURPOSE: Most large acute stroke trials have been neutral. Functional outcome is usua...
ObjectivesUnderpowered trials risk inaccurate results. Recruitment to stroke rehabilitation randomis...
Background and Purpose—Only a few randomized controlled trials in acute stroke have shown a treatmen...
OBJECTIVES: Underpowered trials risk inaccurate results. Recruitment to stroke rehabilitation random...
Background and purpose: Arguments persist as to whether parametric or nonparametric methods should b...
Background and Purpose—Vascular prevention trials mostly count “yes/no” (binary) outcome events, eg,...
Common outcome scales in acute stroke trials are ordered categorical or pseudocontinuous in structur...
Common outcome scales in acute stroke trials are ordered categorical or pseudocontinuous in structur...
Objective: To compare how 3 common representations (ordinal vs dichotomized as 0–1/2–6 or 0–2/3–6) o...
Background and Purpose— There is a lack of agreement regarding measuring the effects of stroke treat...